Rite Aid Target Price and Analyst Consensus

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>RA</div>
RAD -- USA Stock  

Fiscal Quarter End: 31st of August 2020  

The current analyst and expert consensus on Rite Aid is Hold, with 0 strong sell and 0 strong buy opinions. The current projected Rite Aid target price consensus is 17.5 with 2 analyst opinions. The most common way Rite Aid analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Rite Aid executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Rite Aid. We encourage you to use your own analysis of Rite Aid to validate this buy or sell advice. Rite Aid buy or sell recommendation module provides average expert sentiment on the projected Rite Aid target price to derive its highest and lowest estimates based on projected price volatility of 0.707. Additionally, take a look at Macroaxis Advice on Rite Aid to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Search Analyst Recommendations

As of July 13, 2020, Gross Profit is expected to decline to about 6.1 B. In addition to that, Profit Margin is expected to decline to -2.12The current year Book Value per Share is expected to grow to 0.07. The current year Price to Book Value is expected to grow to 133.35.

Rite Aid Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Rite Aid target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Rite Aid target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Number of Opinions3
Lowered Outlook0
Raized Outlook0
Most Rite Aid analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Rite Aid stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Rite Aid, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Rite Aid Target Price Projection

Current Price

Rite Aid Market Quote on 13th of July 2020

Low Price14.9Odds
High Price16.33Odds


Target Price

Analyst Consensus On Target Price

Low Estimate17.0Odds
High Estimate18.0Odds
Number of Analysts2
Standard Deviation0.707


Rite Aid Analysit Ratings

Average Consensus

About Rite Aid Target Price Projections

Rite Aid's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Rite Aid and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Rite Aid depends on its intrinsic valuation, beta (i.e. risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Rite Aid
 2019 2020 (projected)
Long Term Debt to Equity4.594.71
Interest Coverage0.380.39
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page